Skip to main content
. 2021 May 19;12:668760. doi: 10.3389/fimmu.2021.668760

Figure 4.

Figure 4

RvD1 modulates the proliferation and differentiation of Treg and Th17 in PBMCs and naïve CD4+ T cells in SLE patients. (A) The percentages of Treg and Th17 in human PBMCs with and without RvD1 treatment (n=7). (B) Flow cytometric analysis of Treg and Th17, which were differentiated from human naïve CD4+ T cells in the presence or absence of RvD1 (n=5). (C) The level of TGF-β, IL-10, and IL-17 in the culture supernatant were detected by ELISA (n=5). All data are mean ± SEM. *p < 0.05.